nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—SLC22A2—nephron—nephrolithiasis	0.105	0.253	CbGeAlD
Amantadine—DDC—nephron tubule—nephrolithiasis	0.0275	0.0664	CbGeAlD
Amantadine—DDC—renal system—nephrolithiasis	0.025	0.0604	CbGeAlD
Amantadine—DDC—kidney—nephrolithiasis	0.0241	0.0584	CbGeAlD
Amantadine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0238	0.114	CbGpPWpGaD
Amantadine—DDC—cortex of kidney—nephrolithiasis	0.0235	0.0569	CbGeAlD
Amantadine—SLC22A2—nephron tubule—nephrolithiasis	0.0226	0.0547	CbGeAlD
Amantadine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0222	0.107	CbGpPWpGaD
Amantadine—SLC22A2—renal system—nephrolithiasis	0.0206	0.0497	CbGeAlD
Amantadine—SLC22A2—kidney—nephrolithiasis	0.0199	0.0481	CbGeAlD
Amantadine—SLC22A2—cortex of kidney—nephrolithiasis	0.0194	0.0468	CbGeAlD
Amantadine—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0155	0.0411	CcSEcCtD
Amantadine—SIGMAR1—nephron tubule—nephrolithiasis	0.0148	0.0357	CbGeAlD
Amantadine—SLC22A1—renal system—nephrolithiasis	0.0145	0.0351	CbGeAlD
Amantadine—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0382	CcSEcCtD
Amantadine—MAOB—nephron tubule—nephrolithiasis	0.0141	0.0342	CbGeAlD
Amantadine—SLC22A1—kidney—nephrolithiasis	0.014	0.034	CbGeAlD
Amantadine—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0361	CcSEcCtD
Amantadine—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0354	CcSEcCtD
Amantadine—MAOB—renal system—nephrolithiasis	0.0129	0.0311	CbGeAlD
Amantadine—SIGMAR1—cortex of kidney—nephrolithiasis	0.0126	0.0306	CbGeAlD
Amantadine—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0332	CcSEcCtD
Amantadine—MAOB—kidney—nephrolithiasis	0.0124	0.03	CbGeAlD
Amantadine—MAOB—cortex of kidney—nephrolithiasis	0.0121	0.0292	CbGeAlD
Amantadine—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0315	CcSEcCtD
Amantadine—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0309	CcSEcCtD
Amantadine—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0306	CcSEcCtD
Amantadine—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.011	0.029	CcSEcCtD
Amantadine—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0271	CcSEcCtD
Amantadine—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.01	0.0264	CcSEcCtD
Amantadine—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00912	0.0241	CcSEcCtD
Amantadine—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00864	0.0228	CcSEcCtD
Amantadine—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00845	0.0223	CcSEcCtD
Amantadine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00783	0.0207	CcSEcCtD
Amantadine—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00775	0.0205	CcSEcCtD
Amantadine—DDC—Amino acid and derivative metabolism—GRHPR—nephrolithiasis	0.00771	0.037	CbGpPWpGaD
Amantadine—Tension—Hydrochlorothiazide—nephrolithiasis	0.00749	0.0198	CcSEcCtD
Amantadine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00741	0.0196	CcSEcCtD
Amantadine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00719	0.019	CcSEcCtD
Amantadine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00715	0.0189	CcSEcCtD
Amantadine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00701	0.0185	CcSEcCtD
Amantadine—DDC—Amino acid and derivative metabolism—AGXT—nephrolithiasis	0.00687	0.033	CbGpPWpGaD
Amantadine—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00683	0.0181	CcSEcCtD
Amantadine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00675	0.0178	CcSEcCtD
Amantadine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00648	0.0171	CcSEcCtD
Amantadine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00636	0.0168	CcSEcCtD
Amantadine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00628	0.0166	CcSEcCtD
Amantadine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00623	0.0165	CcSEcCtD
Amantadine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00623	0.0165	CcSEcCtD
Amantadine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00608	0.0161	CcSEcCtD
Amantadine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00602	0.0159	CcSEcCtD
Amantadine—DRD2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00597	0.0287	CbGpPWpGaD
Amantadine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00594	0.0157	CcSEcCtD
Amantadine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00582	0.0154	CcSEcCtD
Amantadine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00563	0.0149	CcSEcCtD
Amantadine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00559	0.0148	CcSEcCtD
Amantadine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00555	0.0147	CcSEcCtD
Amantadine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00554	0.0146	CcSEcCtD
Amantadine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00548	0.0145	CcSEcCtD
Amantadine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00542	0.0143	CcSEcCtD
Amantadine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00537	0.0142	CcSEcCtD
Amantadine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00533	0.0141	CcSEcCtD
Amantadine—MAOB—Biological oxidations—SLC26A1—nephrolithiasis	0.00528	0.0254	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—AQP1—nephrolithiasis	0.00519	0.025	CbGpPWpGaD
Amantadine—ABCB1—nephron tubule—nephrolithiasis	0.00516	0.0125	CbGeAlD
Amantadine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00513	0.0136	CcSEcCtD
Amantadine—DRD2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00502	0.0241	CbGpPWpGaD
Amantadine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00492	0.013	CcSEcCtD
Amantadine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00477	0.0229	CbGpPWpGaD
Amantadine—ABCB1—renal system—nephrolithiasis	0.00469	0.0113	CbGeAlD
Amantadine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00459	0.0121	CcSEcCtD
Amantadine—ABCB1—kidney—nephrolithiasis	0.00453	0.011	CbGeAlD
Amantadine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00447	0.0118	CcSEcCtD
Amantadine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00444	0.0213	CbGpPWpGaD
Amantadine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00443	0.0213	CbGpPWpGaD
Amantadine—ABCB1—cortex of kidney—nephrolithiasis	0.00441	0.0107	CbGeAlD
Amantadine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00441	0.0117	CcSEcCtD
Amantadine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00426	0.0113	CcSEcCtD
Amantadine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00413	0.0198	CbGpPWpGaD
Amantadine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00412	0.0109	CcSEcCtD
Amantadine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00396	0.0105	CcSEcCtD
Amantadine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00393	0.0104	CcSEcCtD
Amantadine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00392	0.0104	CcSEcCtD
Amantadine—Headache—Hydrochlorothiazide—nephrolithiasis	0.0039	0.0103	CcSEcCtD
Amantadine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0037	0.00978	CcSEcCtD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00312	0.015	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00291	0.014	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00286	0.0137	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00286	0.0137	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00266	0.0128	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00266	0.0128	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00254	0.0122	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00217	0.0104	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00217	0.0104	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00202	0.0097	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00202	0.0097	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00201	0.00968	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00201	0.00968	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00188	0.00902	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00188	0.00902	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—SPP1—nephrolithiasis	0.00184	0.00883	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00179	0.00862	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—SPP1—nephrolithiasis	0.00179	0.00861	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00178	0.00856	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00178	0.00856	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00167	0.00804	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00166	0.00798	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00166	0.00798	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00159	0.00763	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00148	0.00711	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00145	0.00698	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00145	0.00698	CbGpPWpGaD
Amantadine—DDC—Metabolism—GRHPR—nephrolithiasis	0.00142	0.0068	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00135	0.0065	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00135	0.0065	CbGpPWpGaD
Amantadine—DDC—Metabolism—AGXT—nephrolithiasis	0.00126	0.00606	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GRHPR—nephrolithiasis	0.00119	0.00573	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00115	0.00554	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0011	0.00529	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0011	0.00529	CbGpPWpGaD
Amantadine—DDC—Metabolism—SLC26A1—nephrolithiasis	0.00107	0.00516	CbGpPWpGaD
Amantadine—DDC—Metabolism—APRT—nephrolithiasis	0.00107	0.00516	CbGpPWpGaD
Amantadine—MAOB—Metabolism—AGXT—nephrolithiasis	0.00106	0.0051	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00103	0.00493	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00103	0.00493	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00102	0.00492	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00102	0.00492	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000987	0.00474	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000973	0.00468	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000973	0.00468	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000954	0.00458	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000954	0.00458	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000912	0.00438	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000912	0.00438	CbGpPWpGaD
Amantadine—MAOB—Metabolism—SLC26A1—nephrolithiasis	0.000903	0.00434	CbGpPWpGaD
Amantadine—MAOB—Metabolism—APRT—nephrolithiasis	0.000903	0.00434	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00087	0.00418	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000867	0.00417	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00085	0.00408	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00085	0.00408	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000793	0.00381	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000793	0.00381	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	0.00079	0.0038	CbGpPWpGaD
Amantadine—DDC—Metabolism—AQP1—nephrolithiasis	0.000764	0.00367	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000752	0.00361	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000729	0.0035	CbGpPWpGaD
Amantadine—DDC—Metabolism—CHRM3—nephrolithiasis	0.000691	0.00332	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—PTH—nephrolithiasis	0.000687	0.0033	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000679	0.00327	CbGpPWpGaD
Amantadine—MAOB—Metabolism—AQP1—nephrolithiasis	0.000643	0.00309	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GRHPR—nephrolithiasis	0.000632	0.00304	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000601	0.00289	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000601	0.00289	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GRHPR—nephrolithiasis	0.000589	0.00283	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000587	0.00282	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CHRM3—nephrolithiasis	0.000582	0.0028	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AGXT—nephrolithiasis	0.000564	0.00271	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000559	0.00269	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000559	0.00269	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	0.000549	0.00264	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	0.000533	0.00256	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AGXT—nephrolithiasis	0.000525	0.00252	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000498	0.00239	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000498	0.00239	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APRT—nephrolithiasis	0.000479	0.0023	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—SLC26A1—nephrolithiasis	0.000479	0.0023	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RGS14—nephrolithiasis	0.000467	0.00224	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SLC26A1—nephrolithiasis	0.000447	0.00215	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APRT—nephrolithiasis	0.000447	0.00215	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000425	0.00204	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000398	0.00191	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	0.000388	0.00187	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000386	0.00185	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PTH—nephrolithiasis	0.000353	0.0017	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000345	0.00166	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AQP1—nephrolithiasis	0.000341	0.00164	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AQP1—nephrolithiasis	0.000318	0.00153	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000315	0.00151	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DGKH—nephrolithiasis	0.000315	0.00151	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CHRM3—nephrolithiasis	0.000309	0.00148	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000308	0.00148	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CHRM3—nephrolithiasis	0.000288	0.00138	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APRT—nephrolithiasis	0.000262	0.00126	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000262	0.00126	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	0.000228	0.0011	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PTH—nephrolithiasis	0.000208	0.001	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000187	0.000896	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000169	0.000811	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SPP1—nephrolithiasis	0.000105	0.000503	CbGpPWpGaD
